Skip to main content
Top
Published in: AIDS and Behavior 1/2020

01-01-2020 | Immunodeficiency | Substantive Review

Self-Disclosure of HIV Status Among Youth Living with HIV: A Global Systematic Review

Authors: Kemesha Gabbidon, Tiffany Chenneville, Tiffany Peless, Sydnee Sheared-Evans

Published in: AIDS and Behavior | Issue 1/2020

Login to get access

Abstract

Self-disclosure of HIV serostatus by youth has been considered an essential component of HIV prevention and medication adherence efforts. Therefore, a comprehensive investigation of disclosure goals, processes, and outcomes is warranted. We conducted a global systematic review in accordance with the 2015 Preferred Items for Reporting Systematic Reviews and Meta-Analysis tool to assess HIV self-disclosure among youth ages 13–24. We identified 5881 articles during our initial search. After screening titles and abstracts and examining articles in greater detail, 33 studies (35 articles) were included in the synthesis. The disclosure process model was used to highlight antecedent goals to self-disclosure including common avoidance goals such as fear of rejection and isolation. While disclosure was associated with negative and positive emotional outcomes and improved medication adherence, there remain concerns regarding the impact of self-disclosure on sexual behaviors. Implications for practice and future directions for research are presented.
PROSPERO registration number: CRD42018097250.
Literature
1.
go back to reference Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS Data 2017; 2017. 978-92-9173-945-5. Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS Data 2017; 2017. 978-92-9173-945-5.
25.
go back to reference Lee B, Oberdorfer P. Risk-taking behaviors among vertically HIV-infected adolescents in Northern Thailand. J Int Assoc Phys AIDS Care. 2008;8:221–8.CrossRef Lee B, Oberdorfer P. Risk-taking behaviors among vertically HIV-infected adolescents in Northern Thailand. J Int Assoc Phys AIDS Care. 2008;8:221–8.CrossRef
34.
go back to reference Siu G, Bakeera-Kitaka S, Kennedy C, Dhabangi A, Kambugu A. HIV serostatus disclosure and lived experiences of adolescents at the Trans…. AIDS Care. 2012;24(5):606–11.CrossRefPubMed Siu G, Bakeera-Kitaka S, Kennedy C, Dhabangi A, Kambugu A. HIV serostatus disclosure and lived experiences of adolescents at the Trans…. AIDS Care. 2012;24(5):606–11.CrossRefPubMed
36.
go back to reference Clum GA, Czaplicki L, Andrinopoulos K, Muessig K, Hamvas L, Ellen, and the Adolescent Medicine JM. Strategies and outcomes of HIV status disclosure in HIV-positive young women with abuse histories. AIDS Patient Care STDS. 2013;27(3):191–200. https://doi.org/10.1089/apc.2012.0441. Clum GA, Czaplicki L, Andrinopoulos K, Muessig K, Hamvas L, Ellen, and the Adolescent Medicine JM. Strategies and outcomes of HIV status disclosure in HIV-positive young women with abuse histories. AIDS Patient Care STDS. 2013;27(3):191–200. https://​doi.​org/​10.​1089/​apc.​2012.​0441.
50.
go back to reference Marhefka SL, Turner DE, Chenneville T. HIV disclosure in pediatric populations: Who, what, when to tell, and then what? In: Chenneville T, editor. A clinical guide to pediatric HIV: bridging the gaps between research and practice. Cham: Springer; 2017. p. 189–228. Marhefka SL, Turner DE, Chenneville T. HIV disclosure in pediatric populations: Who, what, when to tell, and then what? In: Chenneville T, editor. A clinical guide to pediatric HIV: bridging the gaps between research and practice. Cham: Springer; 2017. p. 189–228.
Metadata
Title
Self-Disclosure of HIV Status Among Youth Living with HIV: A Global Systematic Review
Authors
Kemesha Gabbidon
Tiffany Chenneville
Tiffany Peless
Sydnee Sheared-Evans
Publication date
01-01-2020
Publisher
Springer US
Published in
AIDS and Behavior / Issue 1/2020
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-019-02478-9

Other articles of this Issue 1/2020

AIDS and Behavior 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine